Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001455859-10-000005
Filing Date
2010-10-29
Accepted
2010-10-29 15:36:07
Documents
1
Period of Report
2010-10-26

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 1489
  Complete submission text file 0001455859-10-000005.txt   3510
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS BIOTECHNOLOGY, INC. (Issuer) CIK: 0000771856 (see all company filings)

EIN.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O WARBURG PINCUS LLC 466 LEXINGTON AVE NEW YORK NY 10017
Business Address
ACKERMAN JOEL (Reporting) CIK: 0001220630 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-17263 | Film No.: 101151751